Bone Biologics Corp (BBLG) - Product Pipeline Analysis, 2019 Update

Published by Global Data on 12th November 2019 | Ref: 1463928 | This Product Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Global License
$750 | Single User
$1500 | Site License
$2250 | Global License



Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company's technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Bone Biologics Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Bone Biologics Corp Company Overview

Bone Biologics Corp Company Snapshot

Bone Biologics Corp Pipeline Products and Ongoing Clinical Trials Overview

Bone Biologics Corp – Pipeline Analysis Overview

Bone Biologics Corp - Key Facts

Bone Biologics Corp - Major Products and Services

Bone Biologics Corp Pipeline Products by Development Stage

Bone Biologics Corp Ongoing Clinical Trials by Trial Status

Bone Biologics Corp Pipeline Products Overview

NELL-1/DBX Fusion Device

NELL-1/DBX Fusion Device Product Overview

NELL-1/DBX Fusion Device Clinical Trial

NELL-1/DBX Fusion Device - Osteoporosis

NELL-1/DBX Fusion Device - Osteoporosis Product Overview

NELL-1/DBX Fusion Device - Trauma

NELL-1/DBX Fusion Device - Trauma Product Overview


UCS-1 Product Overview

Bone Biologics Corp - Key Competitors

Bone Biologics Corp - Key Employees

Bone Biologics Corp - Locations And Subsidiaries

Head Office

Recent Developments

Bone Biologics Corp, Recent Developments

Mar 25, 2019: Bone Biologics receives Human Research Ethics Committee (HREC) approval for the first center of a multicenter pilot clinical trial to evaluate NB1 (NELL-1/DBX) in Australia

Dec 20, 2017: Bone Biologics: New Preclinical Data For Spine Fusion Demonstrates Osteopromotive Properties

Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director

Jul 06, 2016: Bone Biologics Names Scott D. Boden, MD Chief Medical Advisor

Aug 13, 2015: Bone Biologics Appoints New Chief Executive Officer and a Chief Operating Officer

Dec 09, 2014: Bone Biologics announces appointment of George Oram to its Board of Directors

Nov 12, 2014: Bone Biologics appoints Deina Walsh CFO

Sep 10, 2013: Bone Biologics to Webcast, Live, at on September 12th

Feb 24, 2009: Bone Biologics Completes Primate Trials Using Recombinant Protein And Demineralized Bone Matrix For Spinal Fusion Surgery

Feb 21, 2007: Bone Biologics Taps Cytovance To Manufacture UCB-1



About GlobalData

Contact Us


Additional Details


Global Data

Publisher Information


1463928 | GDME3862PD

Number of Pages


Report Format


Related Reports

Date Published
Price From

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Bone Biologics Corp (BBLG) - Product Pipeline Analysis, 2019 Update | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.